Organon Articles
Batch of positive opinions from Europe's Committee for Medicinal Products for Human Use recent meetings
28 June 2010
Meeting highlights from Europe’s CHMP November 16-19, 2009
23 November 2009
Schering-Plough profits beat forecasts
21 April 2009
$60M exit package for S-P CEO Hassan?
16 March 2009
Organon drug linked with breast cancer
23 February 2009
Schering-Plough invest $60M in R&D units
16 February 2009
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
Lexapro and Zoloft are "best" antidepressants
9 February 2009
APP debuts generic Zemuron in USA
26 January 2009
PDCO meeting sees good news for J&J but a mix for GSK and AZ; Janssen pulls Invega app
12 January 2009
S-P enters agreement with Huya seeking to license drugs from China
22 December 2008
S-P claims superior pipeline to competitors; new drugs could make $7B in next 4 years
8 December 2008
S-P's Saphris effective in schizophrenia relapse
1 December 2008
S-P's sugammadex produces rapid recovery
10 November 2008
S-P profit falls 21%, still up on predictions
27 October 2008
Schering-Plough to cut 1,000 sales jobs
29 September 2008
Schering-Plough closes sale of animal health products to Pfizer
22 September 2008
S-P profit down again on Organon charges
28 July 2008
S-P's Bridion gets nod from EMEA's CHMP
9 June 2008
S-P profit down, sales up on Organon buy
5 May 2008
Schering-Plough plans $1.5B cost cuts due to market pressures and cholesterol drug woes
7 April 2008
Stock Commentary - New York week to March 3, 2008
10 March 2008
Jacqueline Elbonne named as VP of global research quality at SPRI
18 February 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
Pharma majors enter CSN experimental medicines consortium
28 January 2008
Sugammdex filed with Japan's MHLW
28 January 2008
S-P's sugammadex NDA gets priority status
14 January 2008
US FDA accepts NDA for S-P's asenapine
10 December 2007
S-P buys Organon for 11B euros
26 November 2007
FTC clears Schering-Plough buy of Organon
26 November 2007
Organon's asenapine improves PANSS score in schizophrenics
19 November 2007
Endotis acquires three Organon antithrombics
5 November 2007
S-P's 3rd-qtr 2007 net income surges 149%
29 October 2007
EC clears S-P's Organon acquistion
22 October 2007
Review of the annual meeting of the ECNP
22 October 2007
Nine NCEs added to Japan's NHI drug list
8 October 2007
Nobilon to co-ordinate FluVac project
8 October 2007
Europe leads surge in Pharma M&A deal values
1 October 2007
AM Pharma appoints Erik van den Berg as its chief business officer
24 September 2007
Govt pledges $62.4M to DSM's BMM
24 September 2007
Xceleron to conduct microdosing study for Organon
17 September 2007
Stock Commentary - Europe - week to Aug 13, 2007
20 August 2007
Organon's muscle relaxant approved in Japan
6 August 2007
Organon and MRC sign cancer Ab development accord
30 July 2007
S-P's 2nd-quarter 2007 EPS doubles to $0.34
30 July 2007
Sugammadex MAA accepted by EMEA
30 July 2007
Stock Commentary - New York - week to July 16, 2007
23 July 2007
Organon and Dyax in therapeutic antibody accord
23 July 2007
ICI tells Akzo to "put-up-or-shut-up"
16 July 2007
ICI rejects L7.2B Akzo Nobel bid
25 June 2007
Almirall announces new appointments
18 June 2007
Nobilon and Vivalis in EBx licensing accord
4 June 2007
Strong Ph III data for Organon's asenapine
4 June 2007
Organon enters R&D accord with Royal Philips
28 May 2007
Stock Commentary - New York week to May 21, 2007
28 May 2007
Organon stops Livial trial on recurrence trend
28 May 2007
Ph IIIa NOMAC/E2 trial completes recruitment
28 May 2007
Medarex and Organon enter Ab drug accord
21 May 2007
Japanese regulator gives nod to three new drugs
21 May 2007
Stock Commentary - New York week to May 7, 2007
14 May 2007
Schering-Plough 1st-qtr profits leap 55%
30 April 2007
Organon
16 April 2007
Stock Commentary - Europe - week to Mar 19
26 March 2007
Stock Commentary - Europe - week to March 12, 2007
26 March 2007
Stock Commentary - New York week to Mar 12, 2007
26 March 2007
Organon's sugammadex gets enthusiastic review
12 March 2007
Organon and Acrux in drug development deal
12 March 2007
Ligand completes sale of Avinza to King
5 March 2007
Organon and Entelos extend RA R&D accord
26 February 2007
Akzo Nobel's 2006 net income increases 20%
26 February 2007
Akzo Nobel confirms Organon IPO intent
26 February 2007
Pharmacopeia enters R&D pact with Organon
19 February 2007
Diosynth extends deal with PDL on Retavase
12 February 2007
Akzo Nobel determined to float Organon
29 January 2007
Nippon Organon submits mirtazapine
22 January 2007
Organon and AMC to collaborate on RA drug development
15 January 2007
Akzo maintains plans to float Organon
15 January 2007
Organon begins Ph III trial of insomnia drug
22 December 2006
Pfizer and Organon end asenapine accord
4 December 2006
Executive appoinmtnets at Organon BioSciences
13 November 2006
Akzo's income hits 313M euro for 3rd-qtr
23 October 2006
Strong Ph II data for Org 36286
2 October 2006
Schering and Organon end R&D collaboration
25 September 2006
Organon enters research accord with NIBRT
11 September 2006
Stock Commentary - Europe - week to Aug 28, 2006
4 September 2006
Akzo Nobel's 2nd-qtr sales hit 3.57B euros
31 July 2006
Organon's Implanon cleared in USA
24 July 2006
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
